Начало › Рак на белия дроб с недребноклетъчен тип › Илинойс › Cicero
Клинични проучвания за Рак на белия дроб с недребноклетъчен тип в Cicero, IL
24 проучвания за Рак на белия дроб с недребноклетъчен тип търсят участници в обекти в и около Cicero (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Набиране на участнициФаза 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · на 10 мили
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Набиране на участнициФаза 3
- Edward Hines Jr VA Hospital, Hines · на 4 мили
- Advocate Christ Medical Center, Oak Lawn · на 9 мили
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Набиране на участнициФаза 3
- Northwestern Medicine Oak Brook, Oak Brook · на 9 мили
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Набиране на участнициФаза 3
- Hope and Healing Cancer Services, Hinsdale · на 10 мили
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Набиране на участнициФаза 3
- Advocate Christ Medical Center, Oak Lawn · на 9 мили
- Hope and Healing Cancer Services, Hinsdale · на 10 мили
- Endeavor Health, Elmhurst · на 10 мили
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Набиране на участнициФаза 2
- Hope and Healing Clinical Research, Hinsdale · на 10 мили
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Набиране на участнициФаза 3
- Research Site, Hinsdale · на 10 мили
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Набиране на участнициФаза 3
- Affiliated Oncologists, LLC, Chicago Ridge · на 10 мили
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 3
- Research Site, Hinsdale · на 10 мили
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Набиране на участнициФаза 2/3
- Loyola University Medical Center, Maywood · на 5 мили
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Набиране на участнициФаза 3
- Hope and Healing Cancer Services, Hinsdale · на 10 мили
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Набиране на участнициФаза 3
- Affiliated Oncologists, LLC, Chicago Ridge · на 10 мили
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Набиране на участнициФаза 3
- Research Site, Hinsdale · на 10 мили
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Набиране на участнициФаза 3
- Research Site, Hinsdale · на 10 мили
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Набиране на участнициФаза 3
- Northwestern Medicine Oak Brook, Oak Brook · на 9 мили
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Набиране на участнициФаза 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · на 10 мили
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · на 3 мили
- Edward Hines Jr VA Hospital, Hines · на 4 мили
- Loyola University Medical Center, Maywood · на 5 мили
- и още 2
MYLUNG Consortium Part 3: Observational Study
Набиране на участнициНаблюдателно проучване
- Affiliated Oncologists, LLC, Chicago Ridge · на 10 мили
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Edward Hines Jr VA Hospital, Hines · на 4 мили
- Loyola University Medical Center, Maywood · на 5 мили
- Northwestern Medicine Oak Brook, Oak Brook · на 9 мили
- и още 3
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2/3
- Loyola University Medical Center, Maywood · на 5 мили
- Northwestern Medicine Oak Brook, Oak Brook · на 9 мили
- Advocate Christ Medical Center, Oak Lawn · на 9 мили
- и още 2
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Edward Hines Jr VA Hospital, Hines · на 4 мили
- Loyola University Medical Center, Maywood · на 5 мили
- Northwestern Medicine Oak Brook, Oak Brook · на 9 мили
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Набиране на участнициНаблюдателно проучване
- Advocate Christ Medical Center, Oak Lawn · на 9 мили
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · на 9 мили
- Advocate High Tech Medical Park, Palos Heights · на 12 мили
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Набиране на участници
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · на 4 мили
GEMINI-NSCLC: NSCLC Biomarker Study
Набиране на участнициНаблюдателно проучване
- Hope and Healing Cancer Services, Hinsdale · на 10 мили
Проучвания за Рак на белия дроб с недребноклетъчен тип в други градове
- Houston, TX145 проучвания
- New York City, NY121 проучвания
- Arlington, VA104 проучвания
- Nashville, TN97 проучвания
- Boston, MA90 проучвания
- Los Angeles, CA87 проучвания
- St. Louis, MO73 проучвания
- Chicago, IL61 проучвания
- Baltimore, MD60 проучвания
- San Antonio, TX59 проучвания
- Columbus, OH57 проучвания
- Washington, DC55 проучвания
Други проучвания в Cicero
- Рак на белия дроб17 проучвания
- Рак на простатата14 проучвания
- Рак (всички видове)13 проучвания
- Рак на гърдата11 проучвания
- Остра миелоидна левкемия11 проучвания
- Колоректален рак10 проучвания
- Рак на пикочния мехур8 проучвания
- Меланом7 проучвания
- Сърдечно-съдово заболяване7 проучвания
- Метастатичен рак7 проучвания
- Множествен миелом6 проучвания
- Лимфом на Бъркит6 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.